Literature DB >> 32035932

High-mobility group box 1 protein participates in acute lung injury by activating protein kinase R and inducing M1 polarization.

Ruiting Li1, You Shang1, Yuan Yu1, Ting Zhou1, Wei Xiong1, Xiaojing Zou2.   

Abstract

High-mobility group box 1 protein (HMGB1) is a crucial proinflammatory cytokine that contributes to acute lung injury (ALI). Macrophages are known to express the primary receptors (Toll-like receptor [TLR] 2, and TLR4) of HMGB1 for transmitting intracellular signals. Studies have revealed that double-stranded RNA activated protein kinase R (PKR), which is expressed in macrophages, participates in ALI by regulating macrophage polarization and proinflammatory cytokine release, and that PKR is normally activated by a subset of TLRs. The present study investigated whether HMGB1 engages in ALI by activating PKR in macrophages and inducing classically activated macrophage (M1) polarization via TLR2- and TLR4-mediated nuclear factor (NF)-κB signaling pathways. In an vivo mouse model of lipopolysaccharide (LPS)-induced ALI, anti-HMGB1, rHMGB1, LPS-RS (TLR2 and TLR4 antagonist), or C16 (PKR inhibitor) was administered to mice 2 h after LPS challenge or 1 h before LPS challenge. In vitro, bone marrow-derived macrophages from mice primed with LPS were stimulated with or without anti-HMGB1, rHMGB1, LPS-RS, or C16. Our studies revealed that rHMGB1 stimulation induced M1 polarization in ALI, and that anti-HMGB1 and C16 treatments had the opposite effect. Anti-HMGB1 and LPS-RS significantly inhibited LPS-induced PKR expression in macrophages; however, rHMGB1 administration increased PKR expression. These results indicate that HMGB1 participates in the pathogenesis of ALI by activating PKR in macrophages and inducing M1 polarization through TLR2- and TLR4-mediated NF-κB signaling pathways.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute lung injury; HMGB1; M1 polarization; Macrophage; PKR

Year:  2020        PMID: 32035932     DOI: 10.1016/j.lfs.2020.117415

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.

Authors:  Sebastiano Cicco; Gerolamo Cicco; Vito Racanelli; Angelo Vacca
Journal:  Mediators Inflamm       Date:  2020-07-16       Impact factor: 4.711

2.  HMGB1/PI3K/Akt/mTOR Signaling Participates in the Pathological Process of Acute Lung Injury by Regulating the Maturation and Function of Dendritic Cells.

Authors:  Ruiting Li; Xiaojing Zou; Haiyan Huang; Yuan Yu; Hongmei Zhang; Pei Liu; Shangwen Pan; Yaqi Ouyang; You Shang
Journal:  Front Immunol       Date:  2020-06-19       Impact factor: 7.561

3.  Inhibition of HMGB1 Ameliorates the Maternal-Fetal Interface Destruction in Unexplained Recurrent Spontaneous Abortion by Suppressing Pyroptosis Activation.

Authors:  Damin Zhu; Huijuan Zou; Jinxian Liu; Jing Wang; Cong Ma; Jiaqian Yin; Xiaoqing Peng; Danyang Li; Yulu Yang; Yu Ren; Zhiguo Zhang; Ping Zhou; Xiangyan Wang; Yunxia Cao; Xiaofeng Xu
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

Review 4.  The integrated stress response in pulmonary disease.

Authors:  Giulia Emanuelli; Nikou Nassehzadeh-Tabriz; Nick W Morrell; Stefan J Marciniak
Journal:  Eur Respir Rev       Date:  2020-10-01

Review 5.  Damage-Associated Molecular Patterns and Their Signaling Pathways in Primary Blast Lung Injury: New Research Progress and Future Directions.

Authors:  Ning Li; Chenhao Geng; Shike Hou; Haojun Fan; Yanhua Gong
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

Review 6.  Protein Kinase R in Bacterial Infections: Friend or Foe?

Authors:  Robin Smyth; Jim Sun
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

7.  MicroRNA-541-5p REgulates Type II Alveolar Epithelial Cell Proliferation and Activity by Modulating the HMGB1 Expression.

Authors:  Jie Shen; Jun Yan; Qiuyun Wang; Lei Zhuang; Yan Luo
Journal:  Shock       Date:  2022-04-01       Impact factor: 3.454

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.